Page last updated: 2024-10-24

celecoxib and Neutropenia

celecoxib has been researched along with Neutropenia in 3 studies

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research Excerpts

ExcerptRelevanceReference
"Neutropenia was the main side effect of the metronomic therapy."5.38Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012)
"Celecoxib with CCRT was well tolerated; the incidence of symptomatic radiation pneumonitis was 6."2.90Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial. ( Bi, N; Chen, D; Deng, L; Feng, Q; Fu, Z; Hu, C; Hui, Z; Liang, J; Liu, L; Lv, J; Wang, J; Wang, L; Wang, W; Wang, X; Xiao, Z; Yang, X; Zhang, T; Zhou, Z, 2019)
"Unresectable pancreatic cancer has few therapeutic options and a dismal prognosis."2.71Gemcitabine/Irinotecan/celecoxib in pancreatic cancer. ( Campbell, C; Harvey, H; Kerr, S; Legore, K; Lipton, A; Witters, L, 2004)
"Neutropenia was the main side effect of the metronomic therapy."1.38Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, N1
Liang, J1
Zhou, Z1
Chen, D1
Fu, Z1
Yang, X1
Feng, Q1
Hui, Z1
Xiao, Z1
Lv, J1
Wang, X2
Zhang, T1
Deng, L1
Wang, W1
Wang, J1
Liu, L1
Hu, C1
Wang, L1
Nygaard, R1
Kivivuori, SM1
Lipton, A1
Harvey, H1
Witters, L1
Kerr, S1
Legore, K1
Campbell, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer[NCT01503385]Phase 2100 participants (Anticipated)Interventional2011-12-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for celecoxib and Neutropenia

ArticleYear
Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
    JAMA network open, 2019, 12-02, Volume: 2, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Celecoxib; Chemoradi

2019
Gemcitabine/Irinotecan/celecoxib in pancreatic cancer.
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch

2004

Other Studies

1 other study available for celecoxib and Neutropenia

ArticleYear
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
    Anti-cancer drugs, 2012, Volume: 23, Issue:3

    Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherap

2012